GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Physical Therapy Inc (NYSE:USPH) » Definitions » EV-to-EBITDA

US Physical Therapy (US Physical Therapy) EV-to-EBITDA : 21.76 (As of Apr. 26, 2024)


View and export this data going back to 1992. Start your Free Trial

What is US Physical Therapy EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, US Physical Therapy's enterprise value is $1,618.3 Mil. US Physical Therapy's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $74.4 Mil. Therefore, US Physical Therapy's EV-to-EBITDA for today is 21.76.

The historical rank and industry rank for US Physical Therapy's EV-to-EBITDA or its related term are showing as below:

USPH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.61   Med: 17.36   Max: 26.66
Current: 21.76

During the past 13 years, the highest EV-to-EBITDA of US Physical Therapy was 26.66. The lowest was 7.61. And the median was 17.36.

USPH's EV-to-EBITDA is ranked worse than
74.84% of 461 companies
in the Healthcare Providers & Services industry
Industry Median: 13.17 vs USPH: 21.76

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-26), US Physical Therapy's stock price is $101.04. US Physical Therapy's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.110. Therefore, US Physical Therapy's PE Ratio for today is 47.89.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


US Physical Therapy EV-to-EBITDA Historical Data

The historical data trend for US Physical Therapy's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Physical Therapy EV-to-EBITDA Chart

US Physical Therapy Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.63 22.62 18.49 19.53 22.56

US Physical Therapy Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.53 22.23 26.55 21.13 22.56

Competitive Comparison of US Physical Therapy's EV-to-EBITDA

For the Medical Care Facilities subindustry, US Physical Therapy's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


US Physical Therapy's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, US Physical Therapy's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where US Physical Therapy's EV-to-EBITDA falls into.



US Physical Therapy EV-to-EBITDA Calculation

US Physical Therapy's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1618.296/74.375
=21.76

US Physical Therapy's current Enterprise Value is $1,618.3 Mil.
US Physical Therapy's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $74.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


US Physical Therapy  (NYSE:USPH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

US Physical Therapy's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=101.04/2.110
=47.89

US Physical Therapy's share price for today is $101.04.
US Physical Therapy's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.110.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


US Physical Therapy EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of US Physical Therapy's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


US Physical Therapy (US Physical Therapy) Business Description

Traded in Other Exchanges
Address
1300 West Sam Houston Parkway South, Suite 300, Houston, TX, USA, 77042
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Executives
Clayton Trier director 1300 WEST SAM HOUSTON PARKWAY SOUTH, SUITE 300, HOUSTON TX 77042
Kathleen A Gilmartin director 1300 W SAM HOUSTON PKWY S, SUITE 300, HOUSTON TX 77042
Nancy Ham director U.S. PHYSICAL THERAPY INC., 1300 W SAM HOUSTON PARKWAY - SUITE 100, HOUSTON TX 77042
Richard Binstein officer: EVP Gen'l Counsel & Secretary 3733 ROSEMONT PASS, NEWTOWN SQUARE PA 19037
Edward L Kuntz director
Graham D. Reeve officer: COO 1300 W. SAM HOUSTON PARKWAY, SUITE 300, HOUSTON TX 77042
Harris Bernard A Jr director 3411 ERIN KNOLL CT, HOUSTON TX 77059
Carey P Hendrickson officer: Chief Financial Officer, other: Effective 11/9/2020 400 S. RECORD STREET, DALLAS TX 75202
Eric Joseph Williams officer: Chief Operations Officer 1300 SAM HOUSTON PARKWAY W, SUITE 300, HOUSTON TX 77042
Harry S Chapman director 4626 DRAKE FALLS COURT, KATY TX 77450
Christopher J Reading officer: Chief Operating Officer
Mark J Brookner director 1300 W SAM HOUSTON PARKWAY S, STE 300, HOUSTON TX 77042
Regg E. Swanson director, Director 1737 BURKE HOLLOW ROAD, NOLENSVILLE TN 37037
Anne Motsenbocker director 1300 W SAM HOUSTON PARKWAY, SUITE 300, HOUSTON TX 77042
Glenn Mcdowell officer: Chief Operating Officer 1300 W. SAM HOUSTON PKWY S., SUITE 300, HOUSTON TX 77042